TearLab Corp. (OTC:TEAR) lost a patent infringement lawsuit in a Canadian federal court against i-Med Pharma last month, according to the company’s annual report. In Feb. 2016, TearLab alleged that i-Med’s i-Pen Osmolarity test infringed 10 claims of TearLab’s Canadian patent for its own osmolarity test. Both systems are designed to measure the osmolarity of tears […]